The Cigna Group (CI) Financial Statements
Historical financial data — 31 statements covering FY2018–FY2025
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are...
The Cigna Group's revenue increased 11.2% year over year, from $247.12B to $274.90B.
Net income increased 73.5% over the same period, from $3.43B to $5.96B.
Over the 7-year period from FY2018 to FY2025, revenue grew by 465% in total.
Total debt remained relatively stable at $31.46B.
The debt-to-equity ratio stands at 0.75, indicating a moderate leverage profile.
Operating cash flow declined 7.4% to $9.60B.
The Cigna Group maintains a moderate net profit margin of 2.2%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $63.69B+5.2% | $739.0M | $16.13B | $2.58B | $46.0M | $157.64B | $32.80B | $42.09B |
| Q4 FY2024 | $65.65B+3.1% | $1.42B | $16.63B | $2.17B | $5.21B | $155.88B | $31.97B | $41.03B |
| Q1 FY2025 | $65.50B-0.2% | $1.32B | $17.10B | $1.97B | $1.92B | $150.66B | $30.45B | $40.23B |
| Q2 FY2025 | $67.18B+2.6% | $1.53B | $13.91B | $2.31B | $-1.89B | $151.65B | $30.77B | $40.21B |
| Q3 FY2025 | $69.75B+3.8% | $1.87B | $14.22B | $2.58B | $3.42B | $157.92B | $34.04B | $41.80B |
| Q4 FY2025 | $72.47B+3.9% | $1.23B | $14.68B | $2.35B | $6.15B | $157.92B | $31.46B | $41.71B |
| Q1 FY2026 | $68.49B-5.5% | $1.65B | $14.39B | $2.36B | $1.13B | N/A | N/A | N/A |
| Q2 FY2026 | $71.67B+4.6% | $1.66B | $14.96B | $2.68B | $-421.0M | N/A | N/A | N/A |
Balance Sheet Summary (FY2025)
The Cigna Group (CI) Financial Statements & Revenue History
The Cigna Group (CI) is a US-listed stock operating in the Healthcare sector, specifically the Healthcare Plans industry trading at $302.30 with a market capitalization of $80. This page provides 31 historical financial statements for The Cigna Group, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, The Cigna Group reported revenue of $274.9 billion, representing 11.2% year-over-year growth. The net profit margin of 2.2% suggests thin margins. The debt-to-equity ratio of 0.75 reflects moderate leverage.
CI Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows The Cigna Group's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether CI is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track CI's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently The Cigna Group converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of CI's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use CI Financial Data
Investors use The Cigna Group's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare CI's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how CI's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View CI's financial health score, earnings, and pre-market pricing.
Financial data is sourced from The Cigna Group's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.CI trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.